3-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg NOW AVAILABLE     Dear [Recipient's First Name],   Thank you for your interest in receiving updates about new 3-times-a-week COPAXONE® 40 mg. We are happy to bring you the exciting news that 3-times-a-week COPAXONE® 40 mg is now available. We ask that you register with us at www.copaxone.com so that we can learn more about you and start to send you more personalized support and resources.     • Proven effectiveness1 • Demonstrated safety and tolerability profile1 • The #1 prescribed brand for relapsing MS in the US2* • The Shared Solutions® network of personalized support     Take control of your relapsing MS by choosing a therapy with proven results.     Make a commitment—and stay the course with a therapy you trust.     Arrange your treatment around your life—not your life around your treatment.     An established brand, proven benefits—plus the freedom to dose 3 times a week.             For more personalized support and resources               Updates about what matters most to you in your relapsing MS management                     Personalized tools that can help you plan your treatment schedule                     Online reservations for live educational events in your area and national webcasts                                     For support or additional information, please call Shared Solutions® at 1-800-887-8100, or visit www.copaxone.com. Talk to your doctor about getting started with 3-times-a-week COPAXONE® 40 mg.             COPAXONE® (glatiramer acetate injection) is indicated for the treatment of patients with relapsing forms of multiple sclerosis. Important Safety Information Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol. Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again. Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense. A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes. The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information. Your Shared Solutions® Team *Based on total number of prescriptions for relapsing forms of MS (IMS National Rx Audit, September 2013). References: 1. COPAXONE® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc. 2. IMS Health National Prescription Audit, September 2013. Data proprietary to IMS Health. Privacy Policy   |  One-click Unsubscribe   |  Terms of Use COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. © 2014 Teva Neuroscience, Inc. COP-40981 Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211